Skip to main content
. 2019 Apr 29;12:277–283. doi: 10.2147/CCID.S198081

Table 1.

The injected fillers, number of injections, and time to onset

Patient number Patient age Injected product(s) Number of treatments in the 4 years prior to onset of symptoms Time to onset of symptoms
(months after final treatment)
Treatment(s) received
1 32 Teosyal Deep Lines
Belotero Intense
Belotero Volume
4 4 Prednisolone Hyaluronidase
2 31 Teosyal Deep Lines
Juvederm Volbella
Belotero Balance
3 2 Prednisolone
3 29 Teosyal Puresense
Juvederm Volift
2 10 Prednisolone
4 22 Juvederm Volbella
Teosyal Kiss
2 4 Prednisolone
5 40 Juvederm Volbella
Juvederm Voluma
Juvederm Volift
6 6 Prednisolone Hyaluronidase
6 65 Teosyal 2 4 Methyl Prednisolone
7 57 Hylaform
Surgiderm
8 7 Methyl Prednisolone
8 63 Juvederm Volbella
Belotero Balance
5 9 Prednisolone Hyaluronidase
9 41 Juvederm Volbella
Juvederm Voluma
Juvederm Volift
3 3 Prednisolone Hyaluronidase
10 25 Restylane Volyme Restylane Defyne
Belotero Intense
4 5 Prednisolone
11 34 Juvederm Voluma 6 3 Methyl Prednisolone
12 45 Belotero Balance 4 5 Methyl Prednisolone
13 23 Belotero Balance 2 6 Methyl Prednisolone
14 61 Restylane Refyne
Restylane Defyne
6 4 Methyl Prednisolone